Novel formulated form of curcumin inhibits the cell growth in miapaca-2 cells

سال انتشار: 1396
محل انتشار: سومین سمپوزیوم بین المللی سرطان نسترن
کد COI اختصاصی: NASTARANCANSER03_106
زبان مقاله: انگلیسی
تعداد مشاهده: 475

نویسندگان

Department Of Biology, Faculty Of Science, PayameNoor University, Mashhad, Iran

Metabolic Syndrome Research Center, Mashhad University Of Medical Sciences, Mashhad, Iran , Cancer Research Center, Faculty Of Medicine, Mashhad University Of Medical Sciences, Mashhad, Iran

Hassanian Mehr

Department Of Medical Biochemistry, Faculty Of Medicine, Mashhad University Of Medical Sciences, Mashhad, Iran

چکیده

Pancreatic-ductal-adenocarcinoma (PDAC) is amongst the most lethal malignancies, mainly because of its metastatic spread and multifactorial chemoresistance. In spite of the progress in surgical treatment, resulting in increasing resection rates and a decrease in treatment-related morbidity and mortality, the true figures of cure are even today below 3%. Curcumin is a major constituent of Curcuma longa,which exerts its anticancer properties in various human cancers including PC. However, instability at physiological pH, low solubility in water and rapid metabolism results in a low oral bioavailability ofcurcumin. The aim of present study was to evaluate the therapeutic potential of the phytosomal curcumin in PC in vitro model. MiaPaCa-2 cells were cultured in F12 medium with 10% FBS and 1%Penicillin and Streptomycin and incubated at 37 ° C and 5% CO2. In order to evaluate the viability of cells treated with different concentrations of phytosomal curcumin, the MTT assay was used. Curcumininhibited MiaPaCa-2 cell growth, as detected by MTT assay. The in vitro (IC50) phytosomal curcumin proliferation-inhibiting concentration was 1 mM. These data clearly establish the efficacy of phytosomalcurcumin in reducing human pancreatic cancer growth in the examined model. The therapeutic curcumin-based effects, with no limiting side-effects, suggest that phytosomal curcumin may be beneficial in patients with pancreatic cancer.

کلیدواژه ها

Gastric Cancer, Cancer Symptoms, Nutrition and Cancer, Cancer Treatment and Management, Drugs and Cancer

مقالات مرتبط جدید

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.